Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 213,123
  • Shares Outstanding, K 65,375
  • Annual Sales, $ 62,370 K
  • Annual Income, $ -78,980 K
  • EBIT $ -68 M
  • EBITDA $ -60 M
  • 60-Month Beta 0.99
  • Price/Sales 3.25
  • Price/Cash Flow N/A
  • Price/Book 1.79

Options Overview Details

View History
  • Implied Volatility 162.69% ( -14.42%)
  • Historical Volatility 61.22%
  • IV Percentile 89%
  • IV Rank 75.64%
  • IV High 209.58% on 08/28/24
  • IV Low 17.08% on 02/21/24
  • Put/Call Vol Ratio 15.20
  • Today's Volume 81
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 141
  • Open Int (30-Day) 123

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.26
  • Number of Estimates 1
  • High Estimate -0.26
  • Low Estimate -0.26
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +29.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.05 +6.89%
on 11/25/24
3.52 -7.39%
on 11/29/24
+0.09 (+2.84%)
since 11/20/24
3-Month
3.03 +7.59%
on 10/04/24
4.10 -20.49%
on 09/25/24
-0.57 (-14.88%)
since 09/20/24
52-Week
2.70 +20.74%
on 08/06/24
7.37 -55.77%
on 03/05/24
-1.14 (-25.91%)
since 12/20/23

Most Recent Stories

More News
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IMPACT®...

SOPH : 3.26 (+5.16%)
SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an update...

SOPH : 3.26 (+5.16%)
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced a new...

AZN : 65.35 (+1.41%)
SOPH : 3.26 (+5.16%)
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, today announced that L'hôpital...

SOPH : 3.26 (+5.16%)
SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced SOPHiA...

SOPH : 3.26 (+5.16%)
Why Nvidia Stock Investors Should Be Excited About an Upcoming IPO

CoreWeave, a company backed by Nvidia, is preparing to go public in 2025.

MSFT : 436.60 (-0.10%)
ARM : 132.15 (+0.04%)
SOPH : 3.26 (+5.16%)
DELL : 115.77 (+3.40%)
NVDA : 134.70 (+3.08%)
SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that it is...

MSFT : 436.60 (-0.10%)
NVDA : 134.70 (+3.08%)
SOPH : 3.26 (+5.16%)
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced a...

SOPH : 3.26 (+5.16%)
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, and the French Kidney Cancer Research Network...

SOPH : 3.26 (+5.16%)
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it has expanded an existing...

SOPH : 3.26 (+5.16%)

Business Summary

SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights...

See More

Key Turning Points

3rd Resistance Point 3.48
2nd Resistance Point 3.39
1st Resistance Point 3.33
Last Price 3.26
1st Support Level 3.18
2nd Support Level 3.09
3rd Support Level 3.03

See More

52-Week High 7.37
Fibonacci 61.8% 5.59
Fibonacci 50% 5.03
Fibonacci 38.2% 4.48
Last Price 3.26
52-Week Low 2.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar